Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

BACKGROUND: Acromegaly is a rare disease primarily caused by growth hormone (GH)-secreting pituitary adenomas, and its treatment is costly. Moreover, some patients are unresponsive to treatment. Hence, there are increasing efforts to develop new drugs with improved effectiveness for this disease. BI...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Endocrinol Metab (Seoul)
Huvudupphovsmän: Kim, Jean, Oh, Ju Hun, Harlem, Heather, Culler, Michael D., Ku, Cheol Ryong, Lee, Eun Jig
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Endocrine Society 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7090307/
https://ncbi.nlm.nih.gov/pubmed/32207278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.35.1.177
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk